Effectiveness of Jena DMĀ® Herbal Formulation as Complementary Therapy to Conventional Oral Hypoglycemic Agents in Type-2 Diabetes Mellitus: A Quasi-experimental Study. [PDF]
Kiptoo J +5 more
europepmc +1 more source
Evaluation of microalbuminuria in type-2 diabetes mellitus under oral hypoglycemic agents: Association with age, sex, BMI, and renal clearance. [PDF]
Gnanasegaran S +5 more
europepmc +1 more source
The effects of transcription factor 7-like 2 rs7903146 and paired box 4 rs2233580 variants associated with type 2 diabetes on the therapeutic efficacy of hypoglycemic agents. [PDF]
Teerawattanapong N +5 more
europepmc +1 more source
Comparative Effectiveness of Oral Hypoglycemic Agents for Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Using Flash Glucose Monitoring. [PDF]
Venkatachalapathy P +3 more
europepmc +1 more source
Related searches:
ORAL hypoglycemic agents are commonly prescribed drugs. In the United States they account for about 1 percent of all prescriptions.1 This review discusses the pharmacology, mechanisms of action, ef...
John A. Oates +2 more
exaly +3 more sources
Oral Hypoglycemic Agents in Pregnancy
Obstetrics and Gynecology Clinics of North America, 2011Multiple studies have been published illustrating the use of oral hypoglycemic agents in pregnancy. Glyburide and metformin have been shown to be as effective as insulin for the treatment of gestational diabetes. Both are safe with breastfeeding. Although both glyburide and metformin appear safe for the treatment of type 2 diabetes mellitus, more ...
Jerrie S Refuerzo
exaly +3 more sources
Conformational Analysis of Non-Sulfonylurea Hypoglycemic Agents of the Meglitinide Family
Non-sulfonylurea hypoglycemic agents of the meglitinide family such as S3075, repaglinide, KAD-1229, and A-4166, were found to display a comparable U-shaped conformation by molecular modelling, with hydrophobic cycles placed at the extremity of each ...
Laurence Lins +2 more
exaly +2 more sources
Oral agents should not be used in the treatment of patients with asymptomatic maturity-onset diabetes. The indication for sulfonylureas is symptomatic maturity-onset diabetes or excessive hyperglycemia--fasting blood sugar over 300 mg per 100 ml--in the elderly patient who cannot or will not take insulin. The use of biguanides cannot be recommended.
+8 more sources

